Filana Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2009 | -3.2% | -3.2% | — |
| FY2010 | -36.5% | -36.5% | -12.1% |
| FY2011 | -5.9% | -5.9% | -2.6% |
| FY2012 | -26.2% | -26.2% | -6.1% |
| FY2013 | 65.3% | 65.3% | 63.0% |
| FY2014 | -30.9% | -30.9% | -30.3% |
| FY2015 | -48.2% | -48.2% | -44.3% |
| FY2016 | -79.7% | -79.7% | -76.9% |
| FY2017 | -122.8% | -122.8% | -110.0% |
| FY2018 | -33.4% | -33.4% | -32.6% |
| FY2019 | -21.0% | -21.0% | -19.7% |
| FY2020 | -6.9% | -6.9% | -6.7% |
| FY2021 | -12.8% | -12.8% | -12.1% |
| FY2022 | -33.5% | -33.5% | -32.5% |
| FY2023 | -70.7% | -70.7% | -64.1% |
| FY2024 | -16.7% | -16.7% | -15.5% |
| FY2025 | -122.3% | -122.3% | -76.9% |